is a patented molecular adjuvant (EP3007725A1) for the formulation of vaccines. The molecule is a new lipid derivative of marine microalgae with co-stimulatory properties of innate immune cells specialized for the capture and presentation of antigens.
A new algal preparation
Our preparation for topical use is obtained from marine microalgae with antioxidant, anti-inflammatory, analgesic and regenerative antiaging properties. Patent pending.
is a molecule derived from marine microalgae with specific anticancer properties against lung and ovarian cancer. It induces the activation of particular mechanisms of cell death through autophagy in tumour cells without inducing any type of toxicity in somatic cells. Patent pendin
Two antitumor candidates
(piroptotic activity and anti-angiogenic activity)